Neoplasia — MCQs

Neoplasia Indian Medical PG Practice Questions and MCQs

Question 111: Which of the following is NOT a tissue or tumor-specific tumor marker?

A. PSA
B. Calcitonin
C. Catecholamines
D. LDH (Correct Answer)

Explanation: **Explanation:** The core concept behind this question is the distinction between **specific** and **non-specific** tumor markers. A tissue-specific marker is produced by a particular organ or cell type, whereas a non-specific marker reflects general metabolic activity, cell turnover, or tissue damage. [3] **Why LDH is the correct answer:** **LDH (Lactate Dehydrogenase)** is a non-specific enzyme found in almost all body tissues (heart, liver, muscle, RBCs). In oncology, elevated LDH levels indicate high cell turnover or tissue necrosis. While it is used for monitoring and prognosis in conditions like Lymphomas, Germ Cell Tumors (Dysgerminoma), and Ewing sarcoma, it is **not specific** to any single tissue or tumor type. **Analysis of incorrect options:** * **PSA (Prostate-Specific Antigen):** Highly tissue-specific for the **prostate epithelium**. [1] It is used for screening and monitoring prostate adenocarcinoma. * **Calcitonin:** A specific marker produced by the parafollicular C-cells of the thyroid. [2] It is the gold-standard marker for **Medullary Carcinoma of the Thyroid (MTC)**. * **Catecholamines:** Specific metabolites (like VMA and HVA) produced by chromaffin cells. They are diagnostic markers for **Pheochromocytoma** (in adults) and **Neuroblastoma** (in children). **High-Yield Clinical Pearls for NEET-PG:** * **Most specific marker:** PSA (though organ-specific, not cancer-specific). * **Oncofetal Antigens:** AFP (Hepatocellular carcinoma, Yolk sac tumor) and CEA (Colorectal carcinoma). [1] * **Hormones as markers:** hCG (Choriocarcinoma), ACTH (Cushing’s syndrome/Small cell lung cancer). [3] * **CA-125:** Marker for Ovarian cancer (Surface epithelial tumors). * **CA-19-9:** Marker for Pancreatic and Cholangiocarcinoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 346. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 213-214.

Question 112: Which of the following statements is NOT true regarding epithelial-mesenchymal transition (EMT)?

A. It is controlled by the transcription factors SNAIL and TWIST.
B. It involves the downregulation of E-cadherin expression. (Correct Answer)
C. It is integral to the metastasis of carcinomas.
D. Homotypic intercellular adhesion is lost during the process.

Explanation: In the context of this question, the statement **"It involves the downregulation of E-cadherin expression"** is marked as the "correct" answer because it is a **true** statement regarding EMT, but the question asks for the statement that is **NOT true**. *(Note: In standard pathology, all four options provided are actually true statements regarding EMT. If this were a "select the false statement" question, there may be a typographical error in the question source, as E-cadherin downregulation is the hallmark of EMT.)* ### **Understanding Epithelial-Mesenchymal Transition (EMT)** EMT is a biological process where polarized epithelial cells undergo biochemical changes to assume a mesenchymal phenotype. This transition enhances migratory capacity, invasiveness, and resistance to apoptosis. 1. **Why Option B is a hallmark (The Concept):** The most critical step in EMT is the **loss of E-cadherin** (downregulation) [1]. E-cadherin acts as the "glue" in adherens junctions; its disappearance allows cells to detach from the primary tumor mass. 2. **Why Option A is true:** EMT is orchestrated by specific transcription factors, primarily **SNAIL, SLUG, and TWIST** [1]. These factors directly repress E-cadherin expression and activate mesenchymal genes like Vimentin. 3. **Why Option C is true:** EMT is essential for the **invasion-metastasis cascade**. It allows carcinoma cells to break through the basement membrane and enter the circulation (intravasation). 4. **Why Option D is true:** Epithelial cells are defined by **homotypic adhesion** (sticking to like cells). During EMT, these adhesions are lost, and cells gain a spindle-shaped, fibroblast-like morphology. ### **High-Yield NEET-PG Pearls** * **The "Cadherin Switch":** EMT involves the downregulation of **E-cadherin** and the upregulation of **N-cadherin** (Neural cadherin), which promotes motility. * **Biomarkers:** Epithelial markers (E-cadherin, Cytokeratin) decrease, while mesenchymal markers (**Vimentin, Smooth Muscle Actin**) increase. * **Reversibility:** Once metastatic cells reach a distant site, they often undergo the reverse process, **MET (Mesenchymal-Epithelial Transition)**, to form a secondary tumor colony. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 317-318.

Question 113: Loss of heterozygosity is associated with which of the following conditions?

A. Acute myeloid leukemia
B. Acute lymphoblastic leukemia
C. Retinoblastoma (Correct Answer)
D. Acute promyelocytic leukemia

Explanation: **Explanation:** **Loss of Heterozygosity (LOH)** is a critical genetic event in the development of cancer, specifically involving **Tumor Suppressor Genes (TSGs)**. According to **Knudson’s "Two-Hit" Hypothesis**, both alleles of a TSG must be inactivated to trigger oncogenesis [1]. In hereditary cases, the first "hit" is a germline mutation (the individual is heterozygous). The second "hit" is a somatic event (deletion or mutation) that eliminates the remaining functional allele, leading to a "Loss of Heterozygosity" and subsequent tumor formation [3]. **Why Retinoblastoma is Correct:** Retinoblastoma is the classic model for LOH [1]. It involves the **RB1 gene** on chromosome **13q14** [2]. In the familial form, a child inherits one defective RB1 allele. LOH occurs when the second, wild-type allele is lost in a retinal cell, leading to biallelic inactivation and tumor development [1], [2]. **Why Other Options are Incorrect:** * **AML, ALL, and APL (Options A, B, D):** These are primarily characterized by **balanced chromosomal translocations** (e.g., t(15;17) in APL) which create fusion oncogenes (like PML-RARA) or lead to the overexpression of proto-oncogenes. While secondary mutations occur, they are not defined by the classic LOH mechanism seen in TSG-related solid tumors. **High-Yield Clinical Pearls for NEET-PG:** * **RB1 Gene:** Known as the "Governor of the Cell Cycle," it regulates the **G1 to S phase** transition by binding to E2F transcription factors [4]. * **Other LOH Examples:** Li-Fraumeni Syndrome (TP53), Familial Adenomatous Polyposis (APC), and Wilms Tumor (WT1). * **Microscopy Hint:** Look for **Flexner-Wintersteiner rosettes** in Retinoblastoma pathology. * **Clinical Sign:** The most common presenting sign is **Leukocoria** (white pupillary reflex). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 298-300. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298.

Question 114: Gene for Wilm's tumor is located on which chromosome?

A. Chromosome 1
B. Chromosome 10
C. Chromosome 11 (Correct Answer)
D. Chromosome 12

Explanation: **Explanation:** **Correct Option: C (Chromosome 11)** Wilms tumor (Nephroblastoma) is the most common primary renal tumor of childhood. Its pathogenesis is closely linked to the **WT1 (Wilms Tumor 1) gene**, which is located on **Chromosome 11p13** [1]. This gene is essential for normal renal and gonadal development. Mutations or deletions in this region lead to the development of Wilms tumor, often as part of syndromic presentations like WAGR syndrome [1]. Additionally, the **WT2 gene** (associated with Beckwith-Wiedemann syndrome) is located on the same chromosome at **11p15.5**. **Incorrect Options:** * **Option A (Chromosome 1):** While 1p deletions can occur as a secondary genetic hit in Wilms tumor (indicating a poorer prognosis), it is not the primary locus for the Wilms tumor gene. * **Option B (Chromosome 10):** This is the location of the **RET proto-oncogene** (associated with MEN 2A, 2B, and Medullary Thyroid Carcinoma) and the **PTEN gene** (Cowden syndrome). * **Option D (Chromosome 12):** This chromosome is associated with mutations in **KRAS** and is often involved in liposarcomas (MDM2 amplification). **High-Yield Clinical Pearls for NEET-PG:** 1. **WAGR Syndrome:** Wilms tumor, Aniridia, Genitourinary anomalies, and mental Retardation (linked to 11p13 deletion) [1]. 2. **Denys-Drash Syndrome:** Wilms tumor, early-onset nephropathy, and male pseudohermaphroditism (WT1 mutation). 3. **Beckwith-Wiedemann Syndrome (BWS):** Characterized by macroglossia, organomegaly, and hemihypertrophy; linked to the WT2 locus (11p15.5). 4. **Triphasic Morphology:** On histology, Wilms tumor typically shows three components: blastemal, stromal, and epithelial cells. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 487-488.

Question 115: Which of the following epithelial changes commonly signifies a precancerous condition?

A. Dyskeratosis (Correct Answer)
B. Hyperkeratosis
C. Parakeratosis
D. Acanthosis

Explanation: ### **Explanation** **Correct Option: A. Dyskeratosis** Dyskeratosis refers to **premature or abnormal keratinization** of individual cells within the squamous epithelium, occurring below the stratum granulosum. In a healthy epithelium, keratinization is a coordinated process that occurs as cells reach the surface. When cells keratinize prematurely (forming "dyskeratotic cells" or "corpses"), it signifies a loss of normal maturation and cellular control. In the context of neoplasia, dyskeratosis is a hallmark of **epithelial dysplasia** [1] and is frequently seen in conditions like **Squamous Cell Carcinoma in situ** and Actinic Keratosis [1][4]. **Why the other options are incorrect:** * **B. Hyperkeratosis:** This is an increase in the thickness of the *stratum corneum* (the outermost layer). It is a non-specific reaction to chronic friction, inflammation, or irritation (e.g., calluses) and does not inherently imply malignancy [3]. * **C. Parakeratosis:** This is characterized by the persistence of nuclei in the cells of the *stratum corneum*. While seen in inflammatory conditions like **Psoriasis**, it is a sign of rapid cell turnover rather than a primary precancerous change. * **D. Acanthosis:** This refers to diffuse hyperplasia (thickening) of the *stratum spinosum* (prickle cell layer) [3]. It is commonly seen in benign conditions like chronic eczema or *Acanthosis nigricans*. ### **High-Yield NEET-PG Pearls** * **Dysplasia vs. Carcinoma in situ:** Dysplasia involves disordered growth and loss of architectural orientation [4]. If the entire thickness of the epithelium is involved but the basement membrane remains intact, it is termed **Carcinoma in situ** [4]. * **Individual Cell Keratinization:** This is a classic histological feature of **Squamous Cell Carcinoma**. * **Koilocytosis:** Another high-yield epithelial change; it indicates HPV infection (vacuolated cytoplasm with "raisinoid" nuclei) and is a precursor to cervical dysplasia [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, p. 1156. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1007-1008. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1000-1002. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 209-210.

Question 116: Which of the following is NOT a tumor associated with an infectious organism?

A. Hepatocellular carcinoma
B. Non-small cell lung carcinoma (Correct Answer)
C. Gastric carcinoma
D. Nasopharyngeal carcinoma

Explanation: **Explanation:** The correct answer is **Non-small cell lung carcinoma (NSCLC)**. While NSCLC is strongly associated with environmental carcinogens (primarily tobacco smoke, radon, and asbestos) and genetic mutations (EGFR, ALK, KRAS), it has no established causal link with an infectious organism. **Analysis of Options:** * **Hepatocellular carcinoma (HCC):** Strongly associated with chronic viral infections, specifically **Hepatitis B Virus (HBV)** and **Hepatitis C Virus (HCV)**. HBV is a DNA virus that integrates into the host genome, while HCV causes chronic inflammation and cirrhosis [1], [3]. * **Gastric carcinoma:** The most significant risk factor is chronic infection with **_Helicobacter pylori_**. This bacterium induces chronic gastritis and intestinal metaplasia, leading to adenocarcinoma. It is also linked to MALT lymphoma. * **Nasopharyngeal carcinoma:** This tumor has a classic, strong association with the **Epstein-Barr Virus (EBV)**, particularly the undifferentiated (Type 3) variant [1], [2]. It is highly prevalent in Southern China and parts of Africa. **NEET-PG High-Yield Pearls:** 1. **Oncogenic Viruses:** * **HPV (16, 18):** Cervical, Anogenital, and Oropharyngeal cancers [1]. * **HHV-8:** Kaposi Sarcoma [1]. * **HTLV-1:** Adult T-cell Leukemia/Lymphoma [1]. 2. **Bacterial Link:** _H. pylori_ is the only bacterium classified as a Class I carcinogen by the WHO. 3. **Parasitic Link:** _Schistosoma haematobium_ is associated with Squamous Cell Carcinoma of the urinary bladder; _Clonorchis sinensis_ is linked to Cholangiocarcinoma. 4. **Lung Cancer Exception:** While most cancers in this list have "infectious" triggers, lung cancer remains the classic example of "chemical carcinogenesis." **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 219-220. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 220-221. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 215-216.

Question 117: Chimney sweepers' cancer is also known as:

A. Carcinoma of the scrotum (Correct Answer)
B. Carcinoma of the urinary bladder
C. Carcinoma of the testis
D. Carcinoma of the penis

Explanation: **Explanation:** **Chimney sweepers' cancer** refers to **Squamous Cell Carcinoma (SCC) of the scrotum**. This condition holds significant historical and pathological importance as it was the first reported instance of **occupational cancer**. 1. **Why Option A is correct:** In 1775, Sir Percivall Pott identified a direct link between exposure to soot and the high incidence of scrotal cancer in chimney sweeps [1]. The underlying mechanism involves chronic exposure to **Polycyclic Aromatic Hydrocarbons (PAHs)**, specifically **Benzopyrene**, found in coal soot [1]. These carcinogens accumulated in the rugae of the scrotal skin due to poor hygiene, leading to DNA damage and malignant transformation. 2. **Why the other options are incorrect:** * **Option B (Urinary Bladder):** Bladder cancer is strongly associated with occupational exposure to **Aniline dyes** (2-Naphthylamine) and smoking, not coal soot. * **Option C (Testis):** Testicular tumors are typically germ cell tumors (e.g., Seminoma) related to genetic factors or cryptorchidism, rather than external chemical carcinogens. * **Option D (Penis):** Penile SCC is primarily associated with Human Papillomavirus (HPV 16, 18) and poor hygiene (smegma) in uncircumcised males [2], rather than soot exposure. **High-Yield Clinical Pearls for NEET-PG:** * **First Occupational Carcinogen identified:** Soot (Benzopyrene) [1]. * **First Chemical Carcinogen identified:** Percivall Pott’s observation of soot [1]. * **Aflatoxin B1:** Associated with Hepatocellular Carcinoma (found in stored grains/Aspergillus). * **Vinyl Chloride:** Associated with Angiosarcoma of the liver. * **Asbestos:** Associated with Mesothelioma and Bronchogenic carcinoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 421-422. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 975-976.

Question 118: A 25-year-old man presents with bilateral gynecomastia and multiple metastatic tumor nodules in both lung fields. What is the most likely primary site of the cancer?

A. Bone marrow
B. Testicle (Correct Answer)
C. Kidney
D. Islets cells of the pancreas

Explanation: ### Explanation The correct answer is **Testicle**. **Why it is correct:** The clinical presentation of a young male (25 years old) with **bilateral gynecomastia** and **pulmonary metastases** (often described as "cannonball" lesions on X-ray) is a classic presentation for a **Germ Cell Tumor (GCT)** of the testis [1]. * **Mechanism of Gynecomastia:** Certain testicular tumors, particularly **Choriocarcinoma** or mixed GCTs, produce high levels of **human Chorionic Gonadotropin (hCG)** [1], [4]. The alpha subunit of hCG is identical to LH, FSH, and TSH. High hCG levels stimulate Leydig cells to produce estrogen or displace the androgen/estrogen ratio, leading to gynecomastia [1], [2]. * **Metastatic Pattern:** Testicular cancers are notorious for early hematogenous spread to the lungs [1], [4]. **Why the other options are incorrect:** * **Bone marrow:** Hematologic malignancies (like Leukemia/Lymphoma) typically present with cytopenias, lymphadenopathy, or hepatosplenomegaly, not gynecomastia or discrete lung nodules. * **Kidney:** While Renal Cell Carcinoma (RCC) can cause "cannonball" lung metastases, it typically occurs in older adults and is associated with paraneoplastic syndromes like erythrocytosis or hypercalcemia, not gynecomastia. * **Islet cells of the pancreas:** These tumors (e.g., Insulinoma, Gastrinoma) present with metabolic or GI symptoms (hypoglycemia, peptic ulcers) and usually metastasize to the liver rather than the lungs. **High-Yield Clinical Pearls for NEET-PG:** * **Tumor Marker:** In a young man with gynecomastia and lung nodules, always check **serum beta-hCG** and **AFP** [3]. * **Choriocarcinoma:** This is the most aggressive GCT; it spreads hematogenously very early and always produces hCG [4]. * **Leydig Cell Tumors:** These are non-germ cell tumors that can also cause gynecomastia due to direct estrogen production, but they are rarely metastatic to the lungs compared to GCTs [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 510-512. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 513-514. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 512-513. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, p. 982.

Question 119: The tumor suppressor gene p53 induces cell cycle arrest at which phase?

A. G2-M phase
B. S-G2 phase
C. G1-S phase (Correct Answer)
D. G0 phase

Explanation: The **p53 protein**, often called the "Guardian of the Genome," plays a critical role in maintaining genomic stability [1]. When DNA damage occurs, p53 is activated and acts as a transcription factor for **p21 (a CDK inhibitor)** [1]. The p21 protein binds to and inhibits **Cyclin D/CDK4** and **Cyclin E/CDK2** complexes. These complexes are responsible for phosphorylating the Retinoblastoma (Rb) protein [2]. By preventing Rb phosphorylation, p53 keeps Rb in its active, hypophosphorylated state, which binds to E2F transcription factors and prevents the cell from progressing from the **G1 phase to the S phase** [1], [2]. This arrest allows time for DNA repair; if the damage is irreparable, p53 triggers apoptosis via the BAX/BAK pathway. **Analysis of Incorrect Options:** * **G2-M phase:** While p53 can influence the G2-M checkpoint (via 14-3-3σ and GADD45), its **primary and most potent** regulatory action occurs at the G1-S transition [1]. * **S-G2 phase:** This is the period of DNA replication and preparation for mitosis. p53 does not primarily arrest cells at this transition. * **G0 phase:** This is a quiescent state. p53 acts on actively cycling cells that have encountered DNA damage, rather than inducing a permanent exit into G0 from the start. **High-Yield Clinical Pearls for NEET-PG:** * **Li-Fraumeni Syndrome:** A germline mutation in the *TP53* gene leading to a high risk of multiple diverse tumors (Sarcoma, Breast, Leukemia, Adrenal - **SBLA** syndrome). * **Most Common Mutation:** *TP53* is the most commonly mutated gene in human cancers [2]. * **Degradation:** In normal cells, p53 levels are kept low by **MDM2**, which targets it for degradation. * **HPV Association:** The **E6 oncoprotein** of High-risk HPV (16, 18) facilitates the degradation of p53. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 302-303. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 301-302.

Question 120: All of the following are involved in the tumor metastasis cascade except?

A. Fibronectin
B. e-cadherin
C. Type IV collagenase
D. Tyrosine kinase (Correct Answer)

Explanation: **Explanation:** The tumor metastasis cascade is a complex, multi-step process involving the detachment of tumor cells, degradation of the extracellular matrix (ECM), and migration into vessels [1], [2]. **Why Tyrosine Kinase is the correct answer:** Tyrosine kinase is a signaling enzyme involved in **cell growth, differentiation, and oncogenesis** (e.g., BCR-ABL in CML or EGFR in lung cancer). While it plays a crucial role in the *transformation* and *proliferation* of cancer cells, it is not a structural or enzymatic component directly responsible for the physical steps of the metastatic cascade (detachment, invasion, and migration). **Analysis of other options:** * **E-cadherin:** Known as the "intercellular glue," its **downregulation** is the first step in metastasis [1]. Loss of E-cadherin allows tumor cells to detach from the primary mass [3]. * **Type IV Collagenase (MMP-2/MMP-9):** These are Matrix Metalloproteinases (MMPs) secreted by tumor cells to degrade the **basement membrane** (composed largely of Type IV collagen), facilitating tissue invasion [2]. * **Fibronectin:** Tumor cells possess receptors (integrins) that bind to ECM components like fibronectin and laminin. This "attachment" and subsequent "detachment" cycle acts like a "rowing" motion, allowing the cell to migrate through the interstitial tissue [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Gatekeeper of Metastasis:** E-cadherin (encoded by *CDH1* gene). Loss is a hallmark of Epithelial-Mesenchymal Transition (EMT) [3]. * **Most common site of metastasis:** Lymph nodes (overall); Liver (most common visceral organ). * **Seed and Soil Hypothesis:** Proposed by Stephen Paget, explaining why certain tumors metastasize to specific organs (e.g., Prostate to Bone). * **Intravasation vs. Extravasation:** Intravasation is entering the blood/lymph; Extravasation is exiting at a distant site [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 314-315. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 232-233. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 317-318.

Practice by Chapter

Nomenclature and Classification of Tumors

Practice Questions

Characteristics of Benign and Malignant Neoplasms

Practice Questions

Molecular Basis of Cancer

Practice Questions

Carcinogenesis and Carcinogens

Practice Questions

Tumor Progression and Metastasis

Practice Questions

Tumor Markers

Practice Questions

Paraneoplastic Syndromes

Practice Questions

Genetic Basis of Cancer

Practice Questions

Tumor Immunity

Practice Questions

Cancer Epidemiology and Prevention

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Neoplasia — MCQs

Neoplasia — MCQs

On this page

Practice by Chapter

Want unlimited practice?